Bub 1 in Chromosomal Instability and Tumorigenesis
Bub 1 in Chromosomal Instability and Tumorigenesis
批准号:
8025993
负责人:
Jan M. van Deursen
金额:
$27.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2012-04-30
关键词:
AllelesAnaphaseAneuploidyAnimalsBindingBiological AssayBiological ModelsCell SurvivalCellsCessation of lifeCharacteristicsChromosomal InstabilityChromosomal StabilityChromosome PairingChromosomesComplexDataDefectDetectionDevelopmentDiseaseDoseDown-RegulationEmbryoEnsureEpigenetic ProcessExhibitsFibroblastsFunctional disorderGene MutationGenesGoalsHumanIn VitroIncidenceIndium-111KinetochoresKnock-outKnockout MiceLeadMalignant NeoplasmsMetaphaseMetaphase PlateMicrotubulesMitosisMitoticMitotic CheckpointMitotic ChromosomeMitotic spindleMolecularMusMutant Strains MiceMutationNeoplasmsOncogenesPathway interactionsPhysiologicalPreventionResearch PersonnelRoleSeriesSister ChromatidTestingTumor Suppressor GenesUbiquitinationWhole Organismanaphase-promoting complexcancer cellcancer therapycell transformationimprovedinsightknockout genemouse modelmutantnovelpreventprogramssegregationtumortumorigenesisubiquitin-protein ligase
中文摘要
描述(由申请人提供):大多数人类癌症具有异常的染色体含量,也称为非整倍体。然而,非整倍体发展的分子缺陷及其在肿瘤发生中的作用在很大程度上仍不清楚。纺锤体组装检查点是一种监视机制,通过延迟后期开始,直到每个着丝点正确地附着在有丝分裂纺锤体上,确保有丝分裂染色体的准确分离。在某些非整倍性癌症中,有丝分裂检查点基因Bub1、BubR1和Mad2已被发现发生突变。在非整倍体肿瘤中也观察到Bub1和BubR1表达的表观遗传下调。为了研究Bub1在有丝分裂、发育和肿瘤发生中的作用,我们通过使用野生型、敲除型和次形等位基因,生产了一系列Bub1表达以分级方式降低的小鼠。对这些小鼠的初步研究表明,Bub1以剂量依赖性的方式阻止非整倍体和自发肿瘤的发展。来自Bub1含量相对较低的动物的细胞表现出有丝分裂检查点活性缺陷,染色体错误分离频繁,染色体错误分离后存活率增加和大量非整倍体。本研究的总体目标是在分子、细胞和机体水平上解剖Bub1的有丝分裂功能,并确定Bub1功能障碍促进肿瘤发生的机制。在具体目标一中,我们将使用突变小鼠菌株来建立Bub1的生理功能和关键功能域。具体目标二集中在Bub1和Skp1之间的一种新的相互作用,Skp1是scf型E3连接酶的核心成分。我们将通过表达不能结合Skp1的Bub1突变形式的敲入小鼠模型以及体外泛素化试验来检查这种相互作用的功能意义。在具体目标三中,我们将利用我们的Bub1小鼠等位基因系列来建立Bub1促进肿瘤发生的机制,并确定在肿瘤发生中与Bub1合作的癌基因。从这些研究中获得的信息将提高我们对这个关键的有丝分裂调节因子维持染色体稳定性和预防癌症的机制的理解。我们相信,这些信息最终将改善人类癌症的检测、预防和治疗。
英文摘要
DESCRIPTION (provided by applicant): Most human cancers have an abnormal chromosome content, also known as aneuploidy. However, the molecular defects underlying the development of aneuploidy and its role in tumorigenesis remain largely unclear. The spindle assembly checkpoint is a surveillance mechanism that ensures accurate segregation of mitotic chromosomes by delaying anaphase onset until each kinetochore has properly attached to the mitotic spindle. In certain cancers with aneuploidy, mutations have been identified in the mitotic checkpoint genes Bub1, BubR1 and Mad2. Epigenetic downregulation of Bub1 and BubR1 expression has also been observed in aneuploid tumors. To study the role of Bub1 in mitosis, development and tumorigenesis, we produced a series of mice in which expression of Bub1 is reduced in a graded fashion by the use of wild-type, knockout and hypomorphic alleles. Preliminary studies of these mice show that Bub1 prevents aneuploidy and spontaneous tumor development in a dose dependent fashion. Cells from animals with relatively low amounts of Bub1 exhibit defective mitotic checkpoint activity, frequent chromosome missegregation, increased survival after chromosome missegregation and massive aneuploidy. The overall goal of this proposal is to dissect the mitotic functions of Bub1 at the molecular, cellular and organismal levels, and to determine the mechanisms by which Bub1 dysfunction promotes tumorigenesis. In specific aim one, we will use mutant mouse strains to establish the physiological functions and critical functional domains of Bub1. Specific aim two focuses on a novel interaction between Bub1 and Skp1, a core component of SCF-type E3 ligases. We will examine the functional significance of this interaction by using a knockin mouse model expressing a mutant form of Bub1 that cannot bind Skp1 as well as in vitro ubiquitination assays. In specific aim three, we will use our allelic series of Bub1 mice to establish the mechanism by which Bub1-promotes tumorigenesis and to identify cancer genes that cooperate with Bub1 in tumor development. The information gained from these studies will improve our understanding of the mechanisms by which this key mitotic regulator maintains chromosomal stability and prevents cancer. We believe this information will ultimately lead to improved detection, prevention and treatment of cancer in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of senescent cells in late-life tumorigenesis
-
批准号:8984872
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2013
-
负责人:Jan M. van Deursen
-
依托单位:
The role of senescent cells in late-life tumorigenesis
-
批准号:8601177
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2013
-
负责人:Jan M. van Deursen
-
依托单位:
The role of senescent cells in late-life tumorigenesis
-
批准号:8780613
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2013
-
负责人:Jan M. van Deursen
-
依托单位:
The role of senescent cells in late-life tumorigenesis
-
批准号:8435619
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2013
-
负责人:Jan M. van Deursen
-
依托单位:
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression
-
批准号:8340701
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2012
-
负责人:Jan M. van Deursen
-
依托单位:
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression
-
批准号:8862427
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2012
-
负责人:Jan M. van Deursen
-
依托单位:
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression
-
批准号:9079435
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2012
-
负责人:Jan M. van Deursen
-
依托单位:
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression
-
批准号:8515369
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2012
-
负责人:Jan M. van Deursen
-
依托单位:
Transgenic
-
批准号:7945054
-
项目类别:
-
资助金额:$14.21万
-
财政年份:2009
-
负责人:Jan M. van Deursen
-
依托单位:
BUB1 in Chromosomal Instability and Tumorigenesis
-
批准号:8295681
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
BUB1 in Chromosomal Instability and Tumorigenesis
-
批准号:8446963
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
Bub 1 in Chromosomal Instability and Tumorigenesis
-
批准号:7578189
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
BUB1 in Chromosomal Instability and Tumorigenesis
-
批准号:8842095
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
BUB1 in Chromosomal Instability and Tumorigenesis
-
批准号:8658390
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
BUB1 in Chromosomal Instability and Tumorigenesis
-
批准号:9063102
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
Bub 1 in Chromosomal Instability and Tumorigenesis
-
批准号:7390726
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
Bub 1 in Chromosomal Instability and Tumorigenesis
-
批准号:7767668
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2007
-
负责人:Jan M. van Deursen
-
依托单位:
BubR1 in Cancer and Aging
-
批准号:7626820
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:Jan M. van Deursen
-
依托单位:
BubR1 in Cancer and Aging
-
批准号:7457969
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:Jan M. van Deursen
-
依托单位:
BubR1 in Cancer and Aging
-
批准号:8069182
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2002
-
负责人:Jan M. van Deursen
-
依托单位:
国内基金
海外基金
RIF1蛋白在处理超细后期桥(ultrafine anaphase bridge)和保障基因组稳定的作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:陈英伟
-
依托单位: